Acute disseminated encephalomyelitis and COVID-19: A systematic synthesis of worldwide cases

11Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Acute disseminated encephalomyelitis (ADEM) has been reported after coronavirus disease 2019 (COVID-19). In this review, we systematically included worldwide reported cases on this association. We included 30 case reports (pediatric and adults) and explored epidemiological and clinical evidence. We described time to diagnosis, clinical, imaging, and laboratory features, response to treatment regimens, and differences regarding severity. Also, an original case report was presented. Neurologists must be alert to the occurrence of multifocal neurological symptoms with or without encephalopathy in patients recovered from COVID-19. Timely MRI studies should be performed to establish the diagnosis and to consider early corticosteroid-based treatment.

Cite

CITATION STYLE

APA

Zelada-Ríos, L., Pacheco-Barrios, K., Galecio-Castillo, M., Yamunaqué-Chunga, C., Álvarez-Toledo, K., & Otiniano-Sifuentes, R. (2021, October 15). Acute disseminated encephalomyelitis and COVID-19: A systematic synthesis of worldwide cases. Journal of Neuroimmunology. Elsevier B.V. https://doi.org/10.1016/j.jneuroim.2021.577674

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free